U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
125011125011Laparoscopic Sacropexy: Comparison of Mesh AttachmentRecruitingNo Results AvailableVaginal Vault ProlapseProcedure: laparoscopic sacropexy with mid vaginal attachment|Procedure: laparoscopic sacropexy with caudal vaginal attachmenthttps://ClinicalTrials.gov/show/NCT00928239
125012125012Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain MetastasesActive, not recruitingNo Results AvailableBrain Cancer|Neoplasm Metastasis|Cancer of Brain and Nervous System|Metastatic Malignant Neoplasm to BrainProcedure: Fractionated Stereotactic Radiosurgery|Device: Linear acceleratorhttps://ClinicalTrials.gov/show/NCT00928226
125013125013PP13 and Doppler Study to Predict PreeclampsiaNot yet recruitingNo Results AvailablePreeclampsiaDrug: Progesterone|Drug: Low molecular weight Heparin|Drug: No Drughttps://ClinicalTrials.gov/show/NCT00928213
125014125014Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)TerminatedNo Results AvailableRelapsed Acute Lymphoblastic Leukemia|Allergy to PEG e.Coli Asparaginase|Allergy to Native e.Coli AsparaginaseDrug: Erwinase|Drug: Vincristine|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Cytarabine|Drug: Methotrexate|Drug: Triple Intrathecal Therapyhttps://ClinicalTrials.gov/show/NCT00928200
125015125015Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)Active, not recruitingNo Results AvailableHIV|HIV InfectionsDrug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line)|Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line)|Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)https://ClinicalTrials.gov/show/NCT00928187
125016125016Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate CancerCompletedHas ResultsProstate CancerDrug: IV administration of fluorine-18 fluorocholine followed by PET/CT imaginghttps://ClinicalTrials.gov/show/NCT00928174
125017125017Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNo Results AvailableHead and Neck Cancer|Oropharyngeal Cancer|Gastroesophageal Reflux DiseaseDrug: Dexlansoprazolehttps://ClinicalTrials.gov/show/NCT00928161
125018125018The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention-Deficit/Hyperactivity DisorderDrug: SPD465|Drug: Immediate Release Amphetamine Salt|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00928148
125019125019Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) SubjectsActive, not recruitingNo Results AvailableCystic FibrosisDrug: Xylitol|Drug: Salinehttps://ClinicalTrials.gov/show/NCT00928135
125020125020Intrastromal Correction of Ametropia by a Femtosecond LaserRecruitingNo Results AvailablePresbyopia|Myopia|Hyperopia|AstigmatismDevice: Intrastromal Correction of Presbyopia|Device: Intrastromal correction of Myopia|Device: Intrastromal Correction of Hyperopia|Device: Intrastromal Correction of Myopia incl. Astigmatism|Device: Intrastromal Correction of Hyperopia incl. Astigmatismhttps://ClinicalTrials.gov/show/NCT00928122
125021125021UCAN: Uniting Couples in the Treatment of Anorexia NervosaCompletedNo Results AvailableAnorexia NervosaBehavioral: CBCT|Behavioral: Family Supportive Therapyhttps://ClinicalTrials.gov/show/NCT00928109
125022125022Breathing Adapted Radiotherapy for Mediastinal LymphomaCompletedNo Results AvailableLymphomahttps://ClinicalTrials.gov/show/NCT00928096
125023125023A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female SubjectsCompletedHas ResultsMalaria Falciparum|Malaria Vivax|Healthy VolunteersDrug: OZ439 50mg API capsules|Drug: OZ439 200mg API capsules|Drug: OZ439 400mg aqueous dispersion|Drug: OZ439 800mg aqueous dispersion|Drug: OZ439 100mg API capsules|Drug: OZ439 400mg API capsules|Drug: OZ439 1600mg aqueous dispersion|Drug: OZ439 800mg API capsules|Drug: OZ439 1200mg API capsules|Drug: Placebo|Drug: OZ439 200mg aqueous dispersionhttps://ClinicalTrials.gov/show/NCT00928083
125024125024A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderCompletedHas ResultsOveractive BladderDrug: Fesoterodine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00928070
125025125025Comparison of Glycemic Control Among Diabetics Using Three Different Pen NeedlesCompletedHas ResultsDiabetes Mellitus, Type 1|Diabetes Mellitus, Type 2Device: 4mm x 32G pen needle|Device: 8mm x 31G pen needle|Device: 5mm x 31G pen needlehttps://ClinicalTrials.gov/show/NCT00928057
125026125026The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)Active, not recruitingNo Results AvailableGynecologic Operations|Anti-Mullerian Hormone|Ovarian Reservehttps://ClinicalTrials.gov/show/NCT00928044
125027125027Long-term Data Collection for Subjects in MDX-010 StudiesCompletedNo Results AvailableMetastatic Melanomahttps://ClinicalTrials.gov/show/NCT00928031
125028125028Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With LymphomaCompletedNo Results AvailableNon-hodgkin Lymphoma|Hodgkin LymphomaDrug: Sirolimus|Drug: Methotrexate|Drug: Tacrolimus|Drug: Cyclosporine|Drug: MMFhttps://ClinicalTrials.gov/show/NCT00928018
125029125029Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)CompletedNo Results AvailableOverweight|Obesity|Type 2 Diabetes|PrediabetesBehavioral: Weight loss diet|Behavioral: Weight loss diet plus exercisehttps://ClinicalTrials.gov/show/NCT00928005
125030125030Study Evaluating Liver Transplantation in Haemophilia Patients in SpainCompletedHas ResultsHemophilia|Hemophilia BOther: Epidemiological Non interventionalhttps://ClinicalTrials.gov/show/NCT00927992
125031125031Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological LaparoscopyCompletedNo Results AvailableGynecological LaparoscopyDrug: 10 mLRopivacaine 1%|Drug: Water for injection|Drug: 10 mL Ropivacaine 1%https://ClinicalTrials.gov/show/NCT00927979
125032125032RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedNo Results AvailableSarcoma|Solid TumorDrug: RAD001|Drug: CP-751,871https://ClinicalTrials.gov/show/NCT00927966
125033125033Treatment of West Nile Virus With MGAWN1TerminatedHas ResultsWest Nile Neuroinvasive Disease|West Nile Virus Infection|Encephalitis|Meningitis|Acute Flaccid Paralysis|West Nile FeverBiological: MGAWN1|Biological: Placebo - normal salinehttps://ClinicalTrials.gov/show/NCT00927953
125034125034RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary StentCompletedHas ResultsArterial Occlusive Diseases|Myocardial Ischemia|Cardiovascular Diseases|Coronary Artery DiseaseDevice: MDT-4107 Drug Eluting Stenthttps://ClinicalTrials.gov/show/NCT00927940
125035125035First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid ArthritisCompletedHas ResultsInflammation|Rheumatoid ArthritisDrug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: placebo|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: NNC0142-0002|Drug: placebohttps://ClinicalTrials.gov/show/NCT00927927
125036125036Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor PolyneuropathyCompletedNo Results AvailableMild to Moderate Diabetic Sensorimotor Polyneuropathy.Drug: Ranirestat|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00927914
125037125037Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With AsthmaCompletedHas ResultsAsthmaDrug: Indacaterol maleate 400 μg|Drug: Indacaterol acetate 400 μg|Drug: Indacaterol xinafoate 400 μg|Drug: Placebo to indacaterolhttps://ClinicalTrials.gov/show/NCT00927901
125038125038Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus SurgeryCompletedHas ResultsPain, PostoperativeDrug: Bupivacaine Blockhttps://ClinicalTrials.gov/show/NCT00927888
125039125039A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableSmall Cell Lung CarcinomaDrug: BMS-833923|Drug: Carboplatin|Drug: Etoposidehttps://ClinicalTrials.gov/show/NCT00927875
125040125040Applying Pharmacogenetic Algorithms to Individualize Dosing of WarfarinCompletedHas ResultsThromboembolismGenetic: IWPC adapted genotype-guided dosing algorithm for warfarin|Genetic: Modified IWPC genetic-guided warfarin dosing algorithm|Other: Standard of care treatmenthttps://ClinicalTrials.gov/show/NCT00927862

* Görseller ve İçerik tekif hakkına sahip olabilir